In particular, we suggest experimental validation of miRNAs hsa-miR-485-3p and hsa-miR-371a-3p and lncRNAs MAP3K14, ERAP1 and SPEN in skin lesions of psoriasis patients treated with biological drugs. Here, MAP3K14 is linked to psoriasis.